{"transactions":[{"id":725991,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:53:14.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0001682069-26-000002","document":"wk-form4_1782507192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000168206926000002/wk-form4_1782507192.xml","form_type":"4"}},{"id":729759,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:35:16.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-26-000076","document":"wk-form4_1782246910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000076/wk-form4_1782246910.xml","form_type":"4"}},{"id":729758,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:35:16.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":14250,"source":{"system":"sec-edgar","filing":"0000805928-26-000076","document":"wk-form4_1782246910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000076/wk-form4_1782246910.xml","form_type":"4"}},{"id":1001039,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":false,"shares":3591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022."}],"balance_after":0,"derivative":{"exercise_price":8.14,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":3591},"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1001038,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":false,"shares":19227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022."}],"balance_after":3591,"derivative":{"exercise_price":8.14,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":19227},"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1001037,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-11","kind":"sale","planned":true,"acquired":false,"shares":3591,"price":24.018,"value":86248.638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.13 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1001036,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":true,"shares":3591,"price":8.14,"value":29230.74,"ownership":{"direct":true},"balance_after":3691,"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1001035,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":19227,"price":24.01,"value":461640.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.10 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1001034,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:31:55.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":true,"shares":19227,"price":8.14,"value":156507.78,"ownership":{"direct":true},"balance_after":19327,"source":{"system":"sec-edgar","filing":"0000805928-25-000136","document":"wk-form4_1763069511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000136/wk-form4_1763069511.xml","form_type":"4"}},{"id":1005398,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-06","kind":"exercise","planned":true,"acquired":false,"shares":5347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022."}],"balance_after":22818,"derivative":{"exercise_price":8.14,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":5347},"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1005397,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":false,"shares":11431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022."}],"balance_after":28165,"derivative":{"exercise_price":8.14,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":11431},"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1005396,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":5347,"price":24.008,"value":128370.776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1005395,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-06","kind":"exercise","planned":true,"acquired":true,"shares":5347,"price":8.14,"value":43524.58,"ownership":{"direct":true},"balance_after":5447,"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1005394,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":11431,"price":24.048,"value":274892.688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1005393,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-07T21:52:34.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":true,"shares":11431,"price":8.14,"value":93048.34,"ownership":{"direct":true},"balance_after":11531,"source":{"system":"sec-edgar","filing":"0000805928-25-000134","document":"wk-form4_1762552351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000134/wk-form4_1762552351.xml","form_type":"4"}},{"id":1011071,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-30","kind":"exercise","planned":true,"acquired":false,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This grant vested on the first anniversary of the date of the grant, June 6, 2024."}],"balance_after":0,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011070,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"exercise","planned":true,"acquired":false,"shares":19799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022."}],"balance_after":39596,"derivative":{"exercise_price":8.14,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":19799},"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011069,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"exercise","planned":true,"acquired":false,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant vested on the first anniversary of the date of the grant, September 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011068,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-30","kind":"sale","planned":true,"acquired":false,"shares":18248,"price":23,"value":419704.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011067,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-30","kind":"exercise","planned":true,"acquired":true,"shares":18248,"price":7.04,"value":128465.92,"ownership":{"direct":true},"balance_after":18348,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011066,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"sale","planned":true,"acquired":false,"shares":19799,"price":22,"value":435578.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011065,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"exercise","planned":true,"acquired":true,"shares":19799,"price":8.14,"value":161163.86,"ownership":{"direct":true},"balance_after":19899,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011064,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"sale","planned":true,"acquired":false,"shares":20436,"price":19.1542,"value":391435.2312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1011063,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T20:09:14.000Z","date":"2025-10-29","kind":"exercise","planned":true,"acquired":true,"shares":20436,"price":6.3,"value":128746.8,"ownership":{"direct":true},"balance_after":20536,"source":{"system":"sec-edgar","filing":"0000805928-25-000132","document":"wk-form4_1761941351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000132/wk-form4_1761941351.xml","form_type":"4"}},{"id":1014045,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T20:09:01.000Z","date":"2025-10-22","kind":"sale","planned":true,"acquired":false,"shares":1457,"price":18.018,"value":26252.226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.045 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000805928-25-000125","document":"wk-form4_1761336538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000125/wk-form4_1761336538.xml","form_type":"4"}},{"id":1022639,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T21:18:08.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":736,"price":18.001,"value":13248.736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.01 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1557,"source":{"system":"sec-edgar","filing":"0000805928-25-000122","document":"wk-form4_1759871884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000122/wk-form4_1759871884.xml","form_type":"4"}},{"id":1023740,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T20:54:19.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":14571,"price":18.2062,"value":265282.5402,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.60 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2293,"source":{"system":"sec-edgar","filing":"0000805928-25-000119","document":"wk-form4_1759784056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000119/wk-form4_1759784056.xml","form_type":"4"}},{"id":1023739,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T20:54:19.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":7600,"price":18.2062,"value":138367.12,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale is from the Elizabeth J. Burke 2024 Irrevocable Trust, of which William P. Burke is a stakeholder and a Trustee."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.60 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000805928-25-000119","document":"wk-form4_1759784056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000119/wk-form4_1759784056.xml","form_type":"4"}},{"id":1023738,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T20:54:19.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":7620,"price":18.0053,"value":137200.386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.02 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":16864,"source":{"system":"sec-edgar","filing":"0000805928-25-000119","document":"wk-form4_1759784056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000119/wk-form4_1759784056.xml","form_type":"4"}},{"id":1023737,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T20:54:19.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":2400,"price":18.01,"value":43224.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale from the Elizabeth J. Burke 2024 Irrevocable Trust, of which William P. Burke is a stakeholder and a Trustee, reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.   The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.04 per share.  The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7600,"source":{"system":"sec-edgar","filing":"0000805928-25-000119","document":"wk-form4_1759784056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000119/wk-form4_1759784056.xml","form_type":"4"}},{"id":1105638,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T20:08:41.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":14150,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-25-000098","document":"wk-form4_1750450115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000098/wk-form4_1750450115.xml","form_type":"4"}},{"id":1115737,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:25:12.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":10.61,"value":43214.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":24484,"source":{"system":"sec-edgar","filing":"0000805928-25-000083","document":"wk-form4_1749673506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000083/wk-form4_1749673506.xml","form_type":"4"}},{"id":1416931,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:52:34.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-24-000118","document":"wk-form4_1725496885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000118/wk-form4_1725496885.xml","form_type":"4"}},{"id":1416930,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:52:34.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on September 1,  2024."}],"balance_after":28557,"source":{"system":"sec-edgar","filing":"0000805928-24-000118","document":"wk-form4_1725496885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000118/wk-form4_1725496885.xml","form_type":"4"}},{"id":1485717,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2024-06-10T22:22:31.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":18248,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-24-000101","document":"wk-form4_1718058141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000101/wk-form4_1718058141.xml","form_type":"4"}},{"id":1485716,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T22:22:31.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":10653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."}],"balance_after":16653,"source":{"system":"sec-edgar","filing":"0000805928-24-000101","document":"wk-form4_1718058141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000101/wk-form4_1718058141.xml","form_type":"4"}},{"id":1712174,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T16:47:55.000Z","date":"2023-12-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":67413,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Previously unvested restricted stock units (\"RSUs\"), each of which represented a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing under the Merger Agreement, each outstanding RSU award was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to the RSU award multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such RSU award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-016375","document":"form4-12132023_091247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000141588923016375/form4-12132023_091247.xml","form_type":"4"}},{"id":1712173,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T16:47:55.000Z","date":"2023-12-12","kind":"other","planned":false,"acquired":false,"shares":66943,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares tendered and accepted pursuant to the terms of an\n offer conducted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, United Therapeutics Corporation (\"Parent\") and Morpheus Subsidiary Inc., dated as of October 29, 2023, for consideration consisting of (i) $3.25 per share, payable in cash, without interest and less any required withholding taxes (the \"Cash Consideration\"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares tendered and accepted pursuant to the terms of an\n offer conducted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, United Therapeutics Corporation (\"Parent\") and Morpheus Subsidiary Inc., dated as of October 29, 2023, for consideration consisting of (i) $3.25 per share, payable in cash, without interest and less any required withholding taxes (the \"Cash Consideration\"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each CVR entitles the reporting person to potentially receive contingent payments of up to an aggregate of $1.75 per CVR, without interest and less any required withholding taxes, upon the achievement of a specified milestone in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"CVR Agreement\"), dated as of December 12, 2023, by and between Parent and Continental Stock Transfer & Trust Company."}],"balance_after":67413,"source":{"system":"sec-edgar","filing":"0001415889-23-016375","document":"form4-12132023_091247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000141588923016375/form4-12132023_091247.xml","form_type":"4"}},{"id":1786368,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-07T10:33:30.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units  of which shares will be delivered to the reporting person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units  of which shares will be delivered to the reporting person upon vesting."}],"balance_after":11904,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-23-000120","document":"wf-form4_169408279774405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000120/wf-form4_169408279774405.xml","form_type":"4"}},{"id":1786367,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2023-09-07T10:33:30.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units  of which shares will be delivered to the reporting person upon vesting."}],"balance_after":20436,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-23-000120","document":"wf-form4_169408279774405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000120/wf-form4_169408279774405.xml","form_type":"4"}},{"id":1797145,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T20:16:36.000Z","date":"2023-08-24","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":6.31,"value":37860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.28 to $6.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000805928-23-000106","document":"wf-form4_169299457138172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000106/wf-form4_169299457138172.xml","form_type":"4"}},{"id":1797144,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T20:16:36.000Z","date":"2023-08-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.56,"value":65600.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in several transactions at prices ranging from $6.54 to $6.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000805928-23-000106","document":"wf-form4_169299457138172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000106/wf-form4_169299457138172.xml","form_type":"4"}},{"id":1866300,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T16:27:24.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":54201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSUs shall vest upon the earlier of (i) the next annual meeting of the stockholders of the Company or (ii) June 1, 2024."}],"balance_after":134356,"source":{"system":"sec-edgar","filing":"0001415889-23-009222","document":"form4-06052023_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000141588923009222/form4-06052023_080618.xml","form_type":"4"}},{"id":1934797,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-30T16:57:16.000Z","date":"2023-03-10","kind":"purchase","planned":false,"acquired":true,"shares":31250,"price":1.6,"value":50000.0,"ownership":{"direct":true},"balance_after":80155,"source":{"system":"sec-edgar","filing":"0001415889-23-005631","document":"form4-03302023_080308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000141588923005631/form4-03302023_080308.xml","form_type":"4"}},{"id":1971631,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Units","published_at":"2023-03-03T17:24:34.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":103686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled."}],"balance_after":103686,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":103686},"source":{"system":"sec-edgar","filing":"0001628280-23-006348","document":"wf-form4_167788223829609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1597313/000162828023006348/wf-form4_167788223829609.xml","form_type":"4"}},{"id":1971630,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T17:24:34.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":103686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 1, 2023, subject to the Reporting Person remaining a service provider through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 356,318 shares granted as RSUs. As of the transaction date, zero  RSUs have vested."}],"balance_after":356318,"source":{"system":"sec-edgar","filing":"0001628280-23-006348","document":"wf-form4_167788223829609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597313/000162828023006348/wf-form4_167788223829609.xml","form_type":"4"}},{"id":2053524,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-17T16:15:24.000Z","date":"2023-01-16","kind":"grant","acquired":true,"shares":252632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of January 16, 2023, subject to the Reporting Person remaining a service provider through each such vesting date."}],"balance_after":252632,"source":{"system":"sec-edgar","filing":"0001628280-23-001109","document":"wf-form4_167399010531321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597313/000162828023001109/wf-form4_167399010531321.xml","form_type":"4"}},{"id":2183772,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T09:36:28.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":12788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\") that will fully vest on the earlier of the next annual meeting or one year from the date of the grant."}],"balance_after":48905,"source":{"system":"sec-edgar","filing":"0001415889-22-008656","document":"form4-08162022_060820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000141588922008656/form4-08162022_060820.xml","form_type":"4"}},{"id":2205871,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-07-19T20:02:16.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":59395,"price":8.14,"value":483475.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on July 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":8.14,"expiration_date":"2023-07-11","underlying":"Stock Option (right to purchase)","underlying_shares":59395},"source":{"system":"sec-edgar","filing":"0000805928-22-000079","document":"wf-form4_165826091626398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000079/wf-form4_165826091626398.xml","form_type":"4"}},{"id":2442934,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:46:32.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":31712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs that vest as follows: 10,571 vest on January 3, 2023; the remaining 21,142 vest thereafter over eight quarters with first five quarters vesting 2,643 each quarter and the final three quarters vesting 2,642 each quarter."}],"balance_after":36117,"source":{"system":"sec-edgar","filing":"0001179110-22-000267","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000117911022000267/edgar.xml","form_type":"4"}},{"id":2442933,"issuer":{"id":96164,"kind":"organization","name":"Miromatrix Medical Inc.","symbol":"MIRO"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:46:32.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":4405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") that vest upon the earlier of (i) the next annual meeting of the company or (ii) one year from the grant date."}],"balance_after":4405,"source":{"system":"sec-edgar","filing":"0001179110-22-000267","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527096/000117911022000267/edgar.xml","form_type":"4"}},{"id":2591659,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-08-25T20:15:51.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":11435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":41.64,"exercise_date":"2021-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":11435},"source":{"system":"sec-edgar","filing":"0000899243-21-034143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924321034143/doc4.xml","form_type":"4"}},{"id":2591658,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-08-25T20:15:51.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":11232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":34.21,"exercise_date":"2020-10-25","expiration_date":"2023-10-25","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0000899243-21-034143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924321034143/doc4.xml","form_type":"4"}},{"id":2591657,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-25T20:15:51.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":22667,"price":60.51,"value":1371580.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted-average price.  These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive.  For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":30291,"source":{"system":"sec-edgar","filing":"0000899243-21-034143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924321034143/doc4.xml","form_type":"4"}},{"id":2591656,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-25T20:15:51.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":11435,"price":41.64,"value":476153.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":52958,"source":{"system":"sec-edgar","filing":"0000899243-21-034143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924321034143/doc4.xml","form_type":"4"}},{"id":2591655,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-25T20:15:51.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":11232,"price":34.21,"value":384246.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":41523,"source":{"system":"sec-edgar","filing":"0000899243-21-034143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924321034143/doc4.xml","form_type":"4"}},{"id":2642925,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-06T20:21:51.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":4293,"price":66.6,"value":285913.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":30291,"source":{"system":"sec-edgar","filing":"0001127602-21-021568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221021568/form4.xml","form_type":"4"}},{"id":2667266,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:31:40.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":190,"price":59.87,"value":11375.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":34584,"source":{"system":"sec-edgar","filing":"0001127602-21-020050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221020050/form4.xml","form_type":"4"}},{"id":2676708,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-09T20:29:22.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":411,"price":55.09,"value":22641.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":34774,"source":{"system":"sec-edgar","filing":"0001127602-21-019522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221019522/form4.xml","form_type":"4"}},{"id":2704376,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-05-20T21:58:34.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":17933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":17933,"derivative":{"exercise_price":56.57,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":17933},"source":{"system":"sec-edgar","filing":"0001127602-21-017677","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017677/form4.xml","form_type":"4"}},{"id":2704375,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:58:34.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":238,"price":55.19,"value":13135.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":35185,"source":{"system":"sec-edgar","filing":"0001127602-21-017677","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017677/form4.xml","form_type":"4"}},{"id":2704374,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:58:34.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":17677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F4","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":35423,"source":{"system":"sec-edgar","filing":"0001127602-21-017677","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017677/form4.xml","form_type":"4"}},{"id":2704373,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:58:34.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":6628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":17746,"source":{"system":"sec-edgar","filing":"0001127602-21-017677","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017677/form4.xml","form_type":"4"}},{"id":2709505,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-18T22:16:26.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":219,"price":55.97,"value":12257.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":11118,"source":{"system":"sec-edgar","filing":"0001127602-21-017257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221017257/form4.xml","form_type":"4"}},{"id":2999013,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-28T20:59:10.000Z","date":"2020-10-26","kind":"sale","acquired":false,"shares":1161,"price":106,"value":123066.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":11337,"source":{"system":"sec-edgar","filing":"0001127602-20-027619","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220027619/form4.xml","form_type":"4"}},{"id":3109850,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":1209,"price":92.09,"value":111336.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.97 to $92.24, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":12498,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3109849,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":6146,"price":91.38,"value":561621.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.95, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":13707,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3109848,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":5259,"price":90.36,"value":475203.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.94 to $90.94, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":19853,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3109847,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":9720,"price":87.71,"value":852541.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the\nreporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the\nreporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":25112,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3109846,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":197,"price":89.29,"value":17590.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":34832,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3109845,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-16T22:16:32.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":22334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":35029,"source":{"system":"sec-edgar","filing":"0001127602-20-019790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019790/form4.xml","form_type":"4"}},{"id":3115572,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-10T21:54:50.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":639,"price":97.03,"value":62002.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":12695,"source":{"system":"sec-edgar","filing":"0001127602-20-019376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220019376/form4.xml","form_type":"4"}},{"id":3144561,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-19T21:10:48.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":10639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":10639,"derivative":{"exercise_price":103.37,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10639},"source":{"system":"sec-edgar","filing":"0001127602-20-017235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017235/form4.xml","form_type":"4"}},{"id":3144560,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-19T21:10:48.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":3144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":13334,"source":{"system":"sec-edgar","filing":"0001127602-20-017235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017235/form4.xml","form_type":"4"}},{"id":3144559,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-19T21:10:48.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":221,"price":100.44,"value":22197.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":10190,"source":{"system":"sec-edgar","filing":"0001127602-20-017235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220017235/form4.xml","form_type":"4"}},{"id":3386831,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-25","kind":"exercise","acquired":false,"shares":11231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":11232,"derivative":{"exercise_price":34.21,"exercise_date":"2019-10-25","expiration_date":"2023-10-25","underlying":"Common Stock","underlying_shares":11231},"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3386830,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-29","kind":"sale","acquired":false,"shares":1448,"price":122.69,"value":177655.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":10411,"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3386829,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-28","kind":"sale","acquired":false,"shares":1155,"price":120.33,"value":138981.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":11859,"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3386828,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-25","kind":"sale","acquired":false,"shares":4326,"price":120.65,"value":521931.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging form $120.38 to $120.97, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":13014,"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3386827,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-25","kind":"sale","acquired":false,"shares":6905,"price":119.87,"value":827702.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.35, inclusive. the reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":17340,"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3386826,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-30T00:20:59.000Z","date":"2019-10-25","kind":"exercise","acquired":true,"shares":11231,"price":34.21,"value":384212.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":24245,"source":{"system":"sec-edgar","filing":"0000899243-19-026127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000089924319026127/doc4.xml","form_type":"4"}},{"id":3394946,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-10T20:52:29.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":11448,"price":124.59,"value":1426306.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.22 to $124.97, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":13014,"source":{"system":"sec-edgar","filing":"0001127602-19-030383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030383/form4.xml","form_type":"4"}},{"id":3394945,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-10T20:52:29.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":8356,"price":123.61,"value":1032885.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.22 to $124.21, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":24462,"source":{"system":"sec-edgar","filing":"0001127602-19-030383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030383/form4.xml","form_type":"4"}},{"id":3394944,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-10T20:52:29.000Z","date":"2019-10-09","kind":"sale","acquired":false,"shares":2900,"price":122.72,"value":355888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.21 to $123.18, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":32818,"source":{"system":"sec-edgar","filing":"0001127602-19-030383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030383/form4.xml","form_type":"4"}},{"id":3394943,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-10T20:52:29.000Z","date":"2019-10-08","kind":"sale","acquired":false,"shares":18950,"price":122.34,"value":2318343.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":35718,"source":{"system":"sec-edgar","filing":"0001127602-19-030383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030383/form4.xml","form_type":"4"}},{"id":3396325,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-08T20:34:25.000Z","date":"2019-10-04","kind":"grant","acquired":true,"shares":41654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned from a performance share unit award granted to the reporting person on October 25, 2016, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from October 1, 2016 to September 30, 2019, as certified by the Compensation Committee of the Board of Directors on October 4, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":54668,"source":{"system":"sec-edgar","filing":"0001127602-19-030268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030268/form4.xml","form_type":"4"}},{"id":3399821,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":5718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":11435,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":5718},"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399820,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":467,"price":128.66,"value":60084.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.55 to $129.00, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":13014,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399819,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":648,"price":127.8,"value":82814.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.99, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":13481,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399818,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":1670,"price":126.72,"value":211622.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.29 to $127.18, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":14129,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399817,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":1309,"price":125.71,"value":164554.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.24 to $126.16, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":15799,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399816,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":3070,"price":124.47,"value":382122.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.21 to $124.98, inclusive. The reporting person undertakes to provide to Haemonetics Corporation (\"Haemonetics\"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":17108,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3399815,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-03T21:22:54.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":5718,"price":41.64,"value":238097.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":20178,"source":{"system":"sec-edgar","filing":"0001127602-19-030039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219030039/form4.xml","form_type":"4"}},{"id":3492056,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-13T20:27:52.000Z","date":"2019-06-12","kind":"sale","acquired":false,"shares":190,"price":109.37,"value":20780.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":14460,"source":{"system":"sec-edgar","filing":"0001127602-19-021560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021560/form4.xml","form_type":"4"}},{"id":3496519,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-10T20:14:39.000Z","date":"2019-06-07","kind":"sale","acquired":false,"shares":411,"price":103.38,"value":42489.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":14650,"source":{"system":"sec-edgar","filing":"0001127602-19-021235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219021235/form4.xml","form_type":"4"}},{"id":3525133,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-05-16T20:15:21.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":10684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":10684,"derivative":{"exercise_price":98.025,"expiration_date":"2026-05-14","underlying":"Common Stock","underlying_shares":10684},"source":{"system":"sec-edgar","filing":"0001127602-19-018729","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219018729/form4.xml","form_type":"4"}},{"id":3525132,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-16T20:15:21.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":3060,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":15061,"source":{"system":"sec-edgar","filing":"0001127602-19-018729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219018729/form4.xml","form_type":"4"}},{"id":3770119,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-11-09T21:25:45.000Z","date":"2018-11-08","kind":"exercise","acquired":false,"shares":11232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant."}],"balance_after":22463,"derivative":{"exercise_price":34.21,"exercise_date":"2017-10-25","expiration_date":"2023-10-25","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001127602-18-032653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218032653/form4.xml","form_type":"4"}},{"id":3770118,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-09T21:25:45.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":13056,"price":114.33,"value":1492692.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":12001,"source":{"system":"sec-edgar","filing":"0001127602-18-032653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218032653/form4.xml","form_type":"4"}},{"id":3770117,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-09T21:25:45.000Z","date":"2018-11-08","kind":"exercise","acquired":true,"shares":11232,"price":34.21,"value":384246.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":25057,"source":{"system":"sec-edgar","filing":"0001127602-18-032653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218032653/form4.xml","form_type":"4"}}],"next_cursor":"2018-11-09T21:25:45.000000Z,3770117"}